ERBB3 and adenosquamous carcinoma: In a recent study on cervical adeno-/adenosquamous carcinoma in Japan, 56.7–77.9% showed high HER3 expression with an increased risk of recurrence (HR 6.32, 95% CI: 1.10–36.26, p = 0.039) [38].